| NCT03928743 |
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT03928743 |
Recruiting |
UCB Pharma |
2021-01-31 |
| NCT03733925 |
A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis |
https://ClinicalTrials.gov/show/NCT03733925 |
Recruiting |
Johnson & Johnson Private Limited |
2021-01-25 |
| NCT03259074 |
Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) |
https://ClinicalTrials.gov/show/NCT03259074 |
Active, not recruiting |
Novartis |
2021-09-02 |
| NCT03211559 |
Clinical Pilates and Aerobic Exercise in Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT03211559 |
Completed |
Eastern Mediterranean University |
2018-12-01 |
| NCT03178487 |
A Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects With Active Ankylosing Spondylitis ( SELECT Axis 1 ) |
https://ClinicalTrials.gov/show/NCT03178487 |
Active, not recruiting |
AbbVie |
2019-01-21 |
| NCT03159767 |
A Clinimetric Test of Spinal Sensors in Measuring Spinal Mobility in Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT03159767 |
Completed |
Western Health and Social Care Trust |
2018-05-02 |
| NCT03140657 |
The Effects of Nanocurcumin on Treg Cells and Th17 Cells Responses in Ankylosing Spondylitis Patients |
https://ClinicalTrials.gov/show/NCT03140657 |
Completed |
Tabriz University of Medical Sciences |
2017-11-07 |
| NCT03117270 |
A Study to Assess Efficacy and Safety of Filgotinib in Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT03117270 |
Completed |
Galapagos NV |
2018-07-02 |
| NCT03033095 |
Prediction of the Answer to the Treatment by Biotherapies for Naive Spondyloarthritis by Combinatorial Analysis of Serum Biomarkers |
https://ClinicalTrials.gov/show/NCT03033095 |
Completed |
University Hospital, Grenoble |
2017-07-31 |
| NCT02915354 |
Relapse of Ankylosing Spondylitis Patients Withdrawal Etanercept After Clinical Remission: a Following-up Study |
https://ClinicalTrials.gov/show/NCT02915354 |
Completed |
Sun Yat-sen University |
2010-09-30 |
| NCT02896127 |
Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT02896127 |
Completed |
Novartis |
2018-05-14 |
| NCT02893254 |
Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT02893254 |
Completed |
Innovent Biologics (Suzhou) Co. Ltd. |
2018-01-22 |
| NCT03215277 |
A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT03215277 |
Completed |
UCB Pharma |
2020-05-25 |
| NCT02763111 |
Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT02763111 |
Completed |
Biocad |
2017-06-30 |
| NCT02763046 |
A Randomized, Double-blind, Placebo-controlled Multicenter Study of Secukinumab (AIN457) to Examine the Clinical Efficacy and the Nonsteroidal Anti-inflammatory Drug (NSAID)-Sparing Effect of Secukinumab Over 16 Weeks in Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT02763046 |
Completed |
Novartis |
2019-09-24 |
| NCT02762812 |
Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT02762812 |
Completed |
Biocad |
2017-05-31 |
| NCT02758782 |
NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT02758782 |
Active, not recruiting |
Charite University, Berlin, Germany |
2020-12-31 |
| NCT02750592 |
Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT02750592 |
Completed |
Novartis |
2017-07-05 |
| NCT02697968 |
Electroacupuncture for Relieving Pain in Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT02697968 |
Completed |
The University of Hong Kong |
2017-09-30 |
| NCT03926195 |
Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT03926195 |
Recruiting |
Galapagos NV |
2021-01-31 |
| NCT02538341 |
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) |
https://ClinicalTrials.gov/show/NCT02538341 |
Active, not recruiting |
University of Alabama at Birmingham |
2019-01-31 |
| NCT02528201 |
A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT02528201 |
Completed |
Pfizer |
2004-11-30 |
| NCT02509026 |
Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA |
https://ClinicalTrials.gov/show/NCT02509026 |
Completed |
Pfizer |
2019-05-28 |
| NCT02503891 |
AL-2 MP-1 (Polyimide) Acetabular Liner |
https://ClinicalTrials.gov/show/NCT02503891 |
Recruiting |
M.M.A Tech Ltd. |
2018-09-30 |
| NCT02469753 |
Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes |
https://ClinicalTrials.gov/show/NCT02469753 |
Recruiting |
University Hospital, Bordeaux |
2023-06-30 |
| NCT02374502 |
Increasing Physical Activity in Ankylosing Spondylitis: a Randomised Controlled Trial |
https://ClinicalTrials.gov/show/NCT02374502 |
Completed |
University of Dublin, Trinity College |
2015-10-31 |
| NCT02359903 |
Comparative Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT02359903 |
Completed |
Biocad |
2015-11-30 |
| NCT02201043 |
Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT02201043 |
Completed |
Shanghai Pharmaceuticals Holding Co., Ltd |
2015-02-28 |
| NCT02186873 |
A Study of Golimumab in Participants With Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT02186873 |
Completed |
Janssen Research & Development, LLC |
2015-12-15 |
| NCT02183168 |
Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT02183168 |
Completed |
Boehringer Ingelheim |
2002-05-31 |
| NCT02159053 |
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT02159053 |
Completed |
Novartis |
2016-02-23 |
| NCT02154425 |
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers |
https://ClinicalTrials.gov/show/NCT02154425 |
Completed |
UCB Pharma |
2015-12-31 |
| NCT02098694 |
Physiotherapy-led Outpatient Clinic for Patients With Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT02098694 |
Completed |
Norwegian University of Science and Technology |
2015-04-30 |
| NCT01351311 |
Resistance Training Exercise Using the Swiss Ball in Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT01351311 |
Completed |
Federal University of São Paulo |
2012-11-30 |
| NCT02047110 |
BI 655066 (Risankizumab) Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS) |
https://ClinicalTrials.gov/show/NCT02047110 |
Completed |
AbbVie |
2015-03-05 |
| NCT03357471 |
Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT03357471 |
Completed |
UCB Pharma |
2018-07-02 |
| NCT03355573 |
A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT03355573 |
Active, not recruiting |
UCB Pharma |
2022-12-31 |
| NCT02008916 |
16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients |
https://ClinicalTrials.gov/show/NCT02008916 |
Completed |
Novartis |
2015-02-23 |
| NCT01988506 |
Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases |
https://ClinicalTrials.gov/show/NCT01988506 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-08-13 |
| NCT01934933 |
Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT01934933 |
Completed |
Sun Yat-sen University |
2015-09-23 |
| NCT01895764 |
Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS) |
https://ClinicalTrials.gov/show/NCT01895764 |
Completed |
University Hospital, Tours |
2015-04-30 |
| NCT01863732 |
Extension in AS: Sustainability of Benefits, Safety and Tolerability |
https://ClinicalTrials.gov/show/NCT01863732 |
Completed |
Novartis |
2018-03-16 |
| NCT01852851 |
Employment and Arthritis: Making it Work |
https://ClinicalTrials.gov/show/NCT01852851 |
Active, not recruiting |
University of British Columbia |
2020-06-30 |
| NCT03350815 |
Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT03350815 |
Recruiting |
Novartis |
2021-05-28 |
| NCT01786668 |
Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT01786668 |
Completed |
Pfizer |
2015-03-31 |
| NCT01709656 |
A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT01709656 |
Completed |
Sun Yat-sen University |
2014-12-31 |
| NCT01690273 |
Exercise Therapy Program in Ankylosing Spondylitis Patients |
https://ClinicalTrials.gov/show/NCT01690273 |
Completed |
University of Sao Paulo |
2013-06-30 |
| NCT01668004 |
The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012) |
https://ClinicalTrials.gov/show/NCT01668004 |
Completed |
Merck Sharp & Dohme Corp. |
2015-04-30 |
| NCT01649375 |
16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT01649375 |
Completed |
Novartis |
2014-08-04 |
| NCT01610947 |
Effect of Spacing of Anti-TNF Drugs in Ankylosing Spondylitis With Low Disease Activity |
https://ClinicalTrials.gov/show/NCT01610947 |
Completed |
University Hospital, Montpellier |
2018-10-31 |
| NCT01586650 |
Effects of Aerobic Training in Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT01586650 |
Completed |
Federal University of São Paulo |
2012-11-30 |
| NCT01583374 |
Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT01583374 |
Completed |
Amgen |
2014-02-24 |
| NCT01571206 |
An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1 |
https://ClinicalTrials.gov/show/NCT01571206 |
Completed |
Celltrion |
2013-05-31 |
| NCT01517620 |
Total Glucosides Paeony Capsules in Maintaining Clinical Remission in Patients With Ankylosing Spondylitis Which Achieve Clinical Remission After Anti-TNF Therapy |
https://ClinicalTrials.gov/show/NCT01517620 |
Completed |
Sun Yat-sen University |
2012-11-30 |
| NCT01463189 |
Web-based Support to Manage Arthritis Pain |
https://ClinicalTrials.gov/show/NCT01463189 |
Completed |
Inflexxion, Inc. |
2012-11-30 |
| NCT01453725 |
Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006) |
https://ClinicalTrials.gov/show/NCT01453725 |
Completed |
Merck Sharp & Dohme Corp. |
2014-03-11 |
| NCT01389388 |
Effects of Rosuvastatin on Carotid Artery Plaques in Patients With Inflammatory Joint Disease |
https://ClinicalTrials.gov/show/NCT01389388 |
Completed |
Diakonhjemmet Hospital |
2013-08-31 |
| NCT01361542 |
Effect Of Anti TNF Alpha Therapy And Their Adverse Effects In Ankylosing Spondylitis In A North Indian Population |
https://ClinicalTrials.gov/show/NCT01361542 |
Completed |
All India Institute of Medical Sciences, New Delhi |
2011-12-31 |
| NCT01358175 |
16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT01358175 |
Completed |
Novartis |
2014-12-31 |
| NCT01330901 |
Ustekinumab for the Treatment of Patients With Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT01330901 |
Completed |
Charite University, Berlin, Germany |
2013-04-30 |
| NCT04436640 |
A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT04436640 |
Enrolling by invitation |
UCB Pharma |
2023-11-30 |
| NCT04400786 |
A Randomized Open-labeled Study for Comparing Methods of Using Imrecoxib to Treat AS |
https://ClinicalTrials.gov/show/NCT04400786 |
Recruiting |
Shanghai Zhongshan Hospital |
2021-12-31 |
| NCT04392596 |
Study of Bone Mineral Density and Trabecular Bone Score in Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT04392596 |
Completed |
Mansoura University |
2020-01-01 |
| NCT04345458 |
Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT04345458 |
Completed |
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. |
2015-07-13 |
| NCT04301128 |
The Effect of Mobile Application on Anti-TNF Drug Adherence of Ankylosing Spondylitis Patients: Pilot Study |
https://ClinicalTrials.gov/show/NCT04301128 |
Completed |
Eskisehir Osmangazi University |
2019-12-31 |
| NCT04292028 |
The Effects of Clinical Pilates Training in Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT04292028 |
Completed |
Dokuz Eylul University |
2018-06-01 |
| NCT04205851 |
Phase 1 Study With KIN-1901 in Healthy Subjects and Subjects With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT04205851 |
Completed |
Kinevant Sciences GmbH |
2020-04-07 |
| NCT04156620 |
Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA |
https://ClinicalTrials.gov/show/NCT04156620 |
Recruiting |
Novartis |
2021-08-09 |
| NCT04135508 |
A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira |
https://ClinicalTrials.gov/show/NCT04135508 |
Completed |
Bio-Thera Solutions |
2018-03-22 |
| NCT04089774 |
Benefit of Adapted Physical Activity for Patients Suffering From Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT04089774 |
Recruiting |
Hospital St. Joseph, Marseille, France |
2022-06-14 |
| NCT04018599 |
Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS |
https://ClinicalTrials.gov/show/NCT04018599 |
Completed |
Fresenius Kabi SwissBioSim GmbH |
2020-03-17 |
| NCT03932006 |
A Multicenter，Double-Blind and Randomized Controlled Trial of Fengshigutong Capsule in the Treatment of Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT03932006 |
Recruiting |
Sun Yat-sen University |
2019-05-31 |
| NCT03904953 |
Effects of Pilates Training on Respiratory Muscle Strenght in Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT03904953 |
Recruiting |
Gazi University |
2019-06-02 |
| NCT03880968 |
Treat-to-Target Strategy With Etanercept for Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT03880968 |
Completed |
Second Affiliated Hospital, School of Medicine, Zhejiang University |
2014-09-30 |
| NCT03807180 |
Effects of Tai Chi in Patients With Ankylosing Spondylitis Receiving Anti-tumor Necrosis Factor Alpha Therapy |
https://ClinicalTrials.gov/show/NCT03807180 |
Completed |
Pamukkale University |
2019-04-30 |
| NCT03800797 |
Efficacy and Safety of Loxoprofen Hydrogel Patch in Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT03800797 |
Completed |
Sun Yat-sen University |
2015-12-10 |
| NCT03726645 |
The Effect of Fecal Microbiota Transplantation in Ankylosing Spondylitis (AS) Patients. |
https://ClinicalTrials.gov/show/NCT03726645 |
Enrolling by invitation |
Hospital District of Helsinki and Uusimaa |
2020-04-30 |
| NCT03667625 |
Stretching in Water and on Land for Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT03667625 |
Completed |
Dokuz Eylul University |
2016-07-31 |
| NCT03639740 |
Treat-to-target With Secukinumab in Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT03639740 |
Recruiting |
Rigshospitalet, Denmark |
2021-02-28 |
| NCT03561649 |
Prediction of Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive SpA |
https://ClinicalTrials.gov/show/NCT03561649 |
Active, not recruiting |
University Hospital, Grenoble |
2019-12-14 |
| NCT03552276 |
A Long Term Study to Demonstrate the Safety and Efficacy of Tildrakizumab in Subjects With Psoriatic Arthritis and Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis. |
https://ClinicalTrials.gov/show/NCT03552276 |
Active, not recruiting |
Sun Pharma Global FZE |
2023-06-30 |
| NCT03502616 |
Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS) |
https://ClinicalTrials.gov/show/NCT03502616 |
Active, not recruiting |
Pfizer |
2019-12-19 |
| NCT03473665 |
Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT03473665 |
Completed |
Columbia University |
2019-08-02 |
| NCT03447704 |
International Multicenter Comparative Randomized Placebo-controlled Clinical Study of Efficacy and Safety of BCD-085 in Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT03447704 |
Active, not recruiting |
Biocad |
2019-03-13 |
| NCT03411798 |
Sequential Application of Yisaipu® and DMARDs in Treating Mild-to-Moderate AS |
https://ClinicalTrials.gov/show/NCT03411798 |
Completed |
Nanfang Hospital of Southern Medical University |
2019-07-01 |
| NCT01258738 |
Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes |
https://ClinicalTrials.gov/show/NCT01258738 |
Completed |
Pfizer |
2012-11-30 |
| NCT01248793 |
Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT01248793 |
Completed |
Centocor, Inc. |
2011-05-31 |
| NCT01220518 |
Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS) |
https://ClinicalTrials.gov/show/NCT01220518 |
Completed |
Celltrion |
2011-11-30 |
| NCT01212653 |
Effect of Anti-TNF (Alpha) Treatment on Vascular Stiffness in Ankylosing Spondylitis (AS) |
https://ClinicalTrials.gov/show/NCT01212653 |
Completed |
Chinese University of Hong Kong |
2013-05-31 |
| NCT01208207 |
A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108) |
https://ClinicalTrials.gov/show/NCT01208207 |
Completed |
Merck Sharp & Dohme Corp. |
2014-11-12 |
| NCT01174186 |
Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing |
https://ClinicalTrials.gov/show/NCT01174186 |
Completed |
Regionshospitalet Silkeborg |
2013-06-30 |
| NCT01114880 |
Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT01114880 |
Completed |
Abbott |
2010-09-30 |
| NCT01109940 |
Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT01109940 |
Completed |
Novartis |
2012-12-31 |
| NCT01091675 |
Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs |
https://ClinicalTrials.gov/show/NCT01091675 |
Completed |
Spanish Foundation of Rheumatology |
2013-05-31 |
| NCT01061723 |
Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT01061723 |
Completed |
Sanofi |
2011-06-30 |
| NCT01038011 |
Efficacy and Safety of Risedronate (Actonel), a Third Generation Bisphosphonate in Patients With Ankylosing Spondylitis: a Phase 2 Pilot Study |
https://ClinicalTrials.gov/show/NCT01038011 |
Completed |
University of Zurich |
NA |
| NCT00953979 |
Efficacy and Safety of Kunxian Capsule in Treatment Patients With Early Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00953979 |
Completed |
Sun Yat-sen University |
2009-09-30 |
| NCT00944658 |
Spondylitis Trial of Apremilast for Better Rheumatic Therapy |
https://ClinicalTrials.gov/show/NCT00944658 |
Completed |
Imperial College London |
2011-01-31 |
| NCT00936143 |
Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00936143 |
Completed |
Sun Yat-sen University |
2009-09-30 |
| NCT00913302 |
Effects of Cardiovascular Training in Individuals With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00913302 |
Completed |
University of Zurich |
2009-11-30 |
| NCT00873730 |
Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain |
https://ClinicalTrials.gov/show/NCT00873730 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2008-06-30 |
| NCT00844805 |
Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1) |
https://ClinicalTrials.gov/show/NCT00844805 |
Completed |
Merck Sharp & Dohme Corp. |
2011-04-30 |
| NCT04125147 |
Clinical Investigation of MONTAGE in Adults With Spinal Deformity Undergoing Pedicle Subtraction Osteotomy |
https://ClinicalTrials.gov/show/NCT04125147 |
Enrolling by invitation |
Abyrx, Inc. |
2021-12-31 |
| NCT00809159 |
Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00809159 |
Completed |
Novartis |
2011-05-31 |
| NCT03457285 |
Investigating the Use of Salaso to Improve Physiotherapy Management of Ankylosing Spondylitis (AS). |
https://ClinicalTrials.gov/show/NCT03457285 |
Recruiting |
St. James’s Hospital, Ireland |
2019-04-17 |
| NCT03092583 |
Analysis of DNA Methylation in Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT03092583 |
Recruiting |
Centre Hospitalier Universitaire de Besancon |
2020-03-31 |
| NCT03074656 |
The Norwegian Drug Monitoring Study |
https://ClinicalTrials.gov/show/NCT03074656 |
Active, not recruiting |
Diakonhjemmet Hospital |
2021-01-01 |
| NCT02963506 |
A Multicenter Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT02963506 |
Completed |
UCB Pharma |
2017-10-31 |
| NCT02505542 |
Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo |
https://ClinicalTrials.gov/show/NCT02505542 |
Completed |
UCB Pharma |
2019-02-28 |
| NCT02019602 |
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta |
https://ClinicalTrials.gov/show/NCT02019602 |
Completed |
UCB Pharma |
2016-10-31 |
| NCT00779935 |
Growth Factor Concentration to Predict an Ankylosing Spondylitis Patient’s Response to Infliximab (Study P04041)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00779935 |
Completed |
Merck Sharp & Dohme Corp. |
2005-10-01 |
| NCT00779012 |
A Study of the Efficacy and Tolerance of Remicade in the Treatment of Active Ankylosing Spondylitis (Study P04042)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00779012 |
Completed |
Merck Sharp & Dohme Corp. |
2007-06-01 |
| NCT00778869 |
Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment (Study P04465)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00778869 |
Completed |
Merck Sharp & Dohme Corp. |
2005-08-31 |
| NCT00764686 |
A Study Investigating an Exercise and Education Programme for Individuals With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00764686 |
Completed |
University College Dublin |
2008-10-31 |
| NCT00762463 |
Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00762463 |
Completed |
Pfizer |
2010-06-30 |
| NCT00722514 |
Evaluation of a Patient Education Program for Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00722514 |
Completed |
Rehazentrum Bad Eilsen |
2001-02-28 |
| NCT00715091 |
Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00715091 |
Completed |
Charite University, Berlin, Germany |
2013-12-31 |
| NCT00667355 |
A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00667355 |
Completed |
Abbott |
2009-05-31 |
| NCT00648141 |
Safety and Efficacy of Celecoxib Versus Diclofenac in the Treatment of Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00648141 |
Completed |
Pfizer |
NA |
| NCT00647517 |
Tramadol/Acetaminophen(Ultracet) AS add-on Therapy in the Treatment of Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00647517 |
Completed |
Chung Shan Medical University |
2009-07-31 |
| NCT00643526 |
A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector |
https://ClinicalTrials.gov/show/NCT00643526 |
Completed |
Centocor, Inc. |
2008-01-31 |
| NCT00576706 |
PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity |
https://ClinicalTrials.gov/show/NCT00576706 |
Completed |
Korea Otsuka Pharmaceutical Co., Ltd. |
2010-03-31 |
| NCT00507403 |
Infliximab and Methotrexate in Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00507403 |
Completed |
University Hospital, Tours |
2009-10-31 |
| NCT00478660 |
An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY) |
https://ClinicalTrials.gov/show/NCT00478660 |
Completed |
Abbott |
NA |
| NCT00458185 |
Study Evaluating Etanercept in Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00458185 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
NA |
| NCT00444340 |
An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00444340 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
NA |
| NCT00439283 |
Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00439283 |
Completed |
Association de Recherche Clinique en Rhumatologie |
NA |
| NCT00434044 |
Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00434044 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
NA |
| NCT00432432 |
Combination Methotrexate and Infliximab |
https://ClinicalTrials.gov/show/NCT00432432 |
Completed |
Chinese University of Hong Kong |
2006-08-31 |
| NCT00421980 |
An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00421980 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
NA |
| NCT00421915 |
Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00421915 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
NA |
| NCT00420238 |
Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00420238 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2009-02-28 |
| NCT00418548 |
Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00418548 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
NA |
| NCT00410046 |
Extension Study Evaluating Etanercept in Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00410046 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2008-10-31 |
| NCT00367211 |
Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers. |
https://ClinicalTrials.gov/show/NCT00367211 |
Completed |
POZEN |
2007-09-30 |
| NCT00356356 |
16.0040 Ankylosing Spondylitis Study |
https://ClinicalTrials.gov/show/NCT00356356 |
Completed |
Amgen |
2006-08-31 |
| NCT00265083 |
A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00265083 |
Completed |
Centocor, Inc. |
2007-03-31 |
| NCT00247962 |
Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00247962 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2008-02-29 |
| NCT00207701 |
A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis. |
https://ClinicalTrials.gov/show/NCT00207701 |
Completed |
Centocor, Inc. |
NA |
| NCT00202865 |
Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (Study P04352) |
https://ClinicalTrials.gov/show/NCT00202865 |
Completed |
Merck Sharp & Dohme Corp. |
2007-05-01 |
| NCT00195819 |
Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00195819 |
Completed |
Abbott |
2004-10-31 |
| NCT00133315 |
TNFalfa Blocking Treatment of Spondylarthropathies |
https://ClinicalTrials.gov/show/NCT00133315 |
Completed |
Hvidovre University Hospital |
NA |
| NCT00126724 |
Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects |
https://ClinicalTrials.gov/show/NCT00126724 |
Completed |
Targeted Genetics Corporation |
2008-10-31 |
| NCT00085644 |
Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00085644 |
Completed |
Abbott |
2004-12-31 |
| NCT00000433 |
Blocking Tumor Necrosis Factor in Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00000433 |
Completed |
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
NA |
| NCT00000416 |
Prevention of Arthritis-Related Work Disability |
https://ClinicalTrials.gov/show/NCT00000416 |
Completed |
Boston University Charles River Campus |
2001-08-31 |
| NCT00004288 |
Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00004288 |
Completed |
Office of Rare Diseases (ORD) |
NA |